Clinical Trials Directory

Trials / Unknown

UnknownNCT01010074

Retinal Function in Parkinson's Disease

Intrinsically Photosensitive Retinal Ganglion Cells in Parkinson's Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

Parkinson's disease (PD) is a neurodegenerative disorder characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex arising from the basal ganglia normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. Included in the symptomatology experienced by patients with PD, visual abnormalities are not uncommon. Visual changes among patients with PD appear not only dynamic in nature, but differentially affected based on the course of the disease and, perhaps more importantly, its treatment. Parkinson's disease has significant ramifications not only in observation of irregularities in vision, but how vision interacts with entrainment of the circadian clock. The purpose of this study is to examine the relationship between PD and operation of a unique set of retinal cells known to regulate the circadian clock and sleep-wake cycles in human subjects.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-11-09
Last updated
2009-11-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01010074. Inclusion in this directory is not an endorsement.